|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Riesco-Martinez MC, Modrego A,
Espinosa-Olarte P, La Salvia A and Garcia-Carbonero R:
Perioperative chemotherapy for liver metastasis of colorectal
cancer: Lessons learned and future perspectives. Curr Treat Options
Oncol. 23:1320–1337. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Panahi MH, Panahi H, Mahdavi Hezaveh A,
Mansournia MA and Bidhendi Yarandi R: Survival rate of colon and
rectum cancer in Iran: A systematic review and meta-analysis.
Neoplasma. 66:988–994. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Amin MB, Edge SB, Greene FL, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC Cancer Staging Manual. 8th edition.
Springer; New York, NY: 2017
|
|
5
|
Liu X, Qin J, Nie J, Sun H, Pan Y and Wang
S: Reclassifying TNM stage I/II colorectal cancer into two
subgroups with different overall survival, tumor microenvironment,
and response to immune checkpoint blockade treatment. Front Genet.
13:9489202022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geng Y, Zhu D and Wu C, Wu J, Wang Q, Li
R, Jiang J and Wu C: A novel systemic inflammation response index
(SIRI) for predicting postoperative survival of patients with
esophageal squamous cell carcinoma. Int Immunopharmacol.
65:503–510. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang Y, Zhu X, Lin Z, Zeng M, Shi P, Cao Y
and Chen F: Compare the diagnostic and prognostic value of MLR, NLR
and PLR in CRC patients. Clin Lab. Sep 1–2021.(Epub ahead of
print). doi: 10.7754/Clin.Lab.2021.201130. View Article : Google Scholar
|
|
8
|
Chen Y, Jiang W, Xi D, Chen J, Xu G, Yin
W, Chen J and Gu W: Development and validation of nomogram based on
SIRI for predicting the clinical outcome in patients with
nasopharyngeal carcinomas. J Investig Med. 67:691–698. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu H, Li Z, Zhang Q, Li Q, Zhong H, Wang
Y, Yang H, Li H, Wang X, Li K, et al: Multi-institutional
development and validation of a nomogram to predict prognosis of
early-onset gastric cancer patients. Front Immunol. 13:10071762022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Y, Chen D, Xuan H, Dragomir MP, Calin
GA, Meng X, Chen M and Jin H: Construction and validation of
prognostic nomogram for metaplastic breast cancer. Bosn J Basic Med
Sci. 22:131–139. 2022.PubMed/NCBI
|
|
11
|
Ogunwobi OO, Mahmood F and Akingboye A:
Biomarkers in colorectal cancer: Current research and future
prospects. Int J Mol Sci. 21:53112020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sugimoto A, Fukuoka T, Shibutani M,
Kasashima H, Kitayama K, Ohira M and Maeda K: Prognostic
significance of the Naples prognostic score in colorectal cancer
patients undergoing curative resection: A propensity score matching
analysis. BMC Gastroenterol. 23:882023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xie T, Wang X, Li M, Tong T, Yu X and Zhou
Z: Pancreatic ductal adenocarcinoma: A radiomics nomogram
outperforms clinical model and TNM staging for survival estimation
after curative resection. Eur Radiol. 30:2513–2524. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hanahan D: Hallmarks of cancer: New
dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kubo H, Murayama Y, Arita T, Kuriu Y,
Nakanishi M and Otsuji E: The prognostic value of preoperative
Neutrophil-to-Lymphocyte ratio in colorectal cancer. World J Surg.
40:2796–2802. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Zhou GQ, Liu X, Chen L, Li WF,
Tang LL, Liu Q, Sun Y and Ma J: Exploration and validation of
C-Reactive Protein/Albumin ratio as a novel Inflammation-based
prognostic marker in nasopharyngeal carcinoma. J Cancer.
7:1406–1412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Misiewicz A and Dymicka-Piekarska V:
Fashionable, but What is their real clinical usefulness? NLR, LMR,
and PLR as a promising indicator in colorectal cancer prognosis: A
systematic review. J Inflamm Res. 16:69–81. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gawiński C, Michalski W, Mróz A and
Wyrwicz L: Correlation between Lymphocyte-to-monocyte ratio (LMR),
Neutrophil-to-Lymphocyte ratio (NLR), Platelet-to-Lymphocyte ratio
(PLR) and Tumor-Infiltrating lymphocytes (TILs) in Left-sided
colorectal cancer patients. Biology (Basel). 11:3852022.PubMed/NCBI
|
|
19
|
Mahsuni Sevinc M, Riza Gunduz U, Kinaci E,
Armagan Aydin A, Bayrak S, Umar Gursu R and Gunduz S: Preoperative
neutrophil-to-lymphocyte ratio and plateletto-lymphocyte ratio as
new prognostic factors for patients with colorectal cancer. J BUON.
21:1153–1157. 2016.PubMed/NCBI
|
|
20
|
Maeda Y, Kawahara T, Koizumi M, Ito H,
Kumano Y, Ohtaka M, Kondo T, Mochizuki T, Hattori Y, Teranishi J,
et al: Lack of an association between Neutrophil-to-Lymphocyte
ratio and PSA failure of prostate cancer patients who underwent
radical prostatectomy. Biomed Res Int. 2016:61973532016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Byun SS, Hwang EC, Kang SH, Hong SH, Chung
J, Kwon TG, Kim HH, Kwak C, Kim YJ and Lee WK: Prognostic
significance of preoperative Neutrophil-to-Lymphocyte ratio in
nonmetastatic renal cell carcinoma: A large, multicenter cohort
analysis. Biomed Res Int. 2016:56341482016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Coffelt SB, Wellenstein MD and de Visser
KE: Neutrophils in cancer: Neutral no more. Nat Rev Cancer.
16:431–446. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng Z, Xu Y, Shi Y and Shao CL:
Neutrophils in the tumor microenvironment and their functional
modulation by mesenchymal stromal cells. Cell Immunol.
379:1045762022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chandra R, Karalis JD, Liu C, Murimwa GZ,
Voth Park J, Heid CA, Reznik SI, Huang E, Minna JD and Brekken RA:
The colorectal cancer tumor microenvironment and its impact on
liver and lung metastasis. Cancers (Basel). 13:62062021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gijsbers K, Gouwy M, Struyf S, Wuyts A,
Proost P, Opdenakker G, Penninckx F, Ectors N, Geboes K and Van
Damme J: GCP-2/CXCL6 synergizes with other endothelial cell-derived
chemokines in neutrophil mobilization and is associated with
angiogenesis in gastrointestinal tumors. Exp Cell Res. 303:331–342.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eck M, Schmausser B, Scheller K, Brändlein
S and Müller-Hermelink HK: Pleiotropic effects of CXC chemokines in
gastric carcinoma: Differences in CXCL8 and CXCL1 expression
between diffuse and intestinal types of gastric carcinoma. Clin Exp
Immunol. 134:508–515. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Que H, Fu Q, Lan T, Tian X and Wei X:
Tumor-associated neutrophils and neutrophil-targeted cancer
therapies. Biochim Biophys Acta Rev Cancer. 877:1887622022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bai Z, Zhou Y, Ye Z, Xiong J, Lan H and
Wang F: Tumor-infiltrating lymphocytes in colorectal cancer: The
fundamental indication and application on immunotherapy. Front
Immunol. 12:8089642021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shin JS, Suh KW and Oh SY: Preoperative
neutrophil to lymphocyte ratio predicts survival in patients with
T1-2N0 colorectal cancer. J Surg Oncol. 112:654–657. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kubo T, Ono S, Ueno H, Shinto E, Yamamoto
J and Hase K: Impact of the perioperative neutrophil-to-lymphocyte
ratio on the long-term survival following an elective resection of
colorectal carcinoma. Int J Colorectal Dis. 29:1091–1099. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Friman TK, Jäämaa-Holmberg S, Åberg F,
Helanterä I, Halme M, Pentikäinen MO, Nordin A, Lemström KB,
Jahnukainen T, Räty R and Salmela B: Cancer risk and mortality
after solid organ transplantation: A population-based 30-year
cohort study in Finland. Int J Cancer. 150:1779–1791. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Slagter AE, Vollebergh MA, Caspers IA, van
Sandick JW, Sikorska K, Lind P, Nordsmark M, Putter H, Braak J,
Meershoek-Klein Kranenbarg E, et al: Prognostic value of tumor
markers and ctDNA in patients with resectable gastric cancer
receiving perioperative treatment: Results from the CRITICS trial.
Gastric Cancer. 25:401–410. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsai PL, Su WJ, Leung WH, Lai CT and Liu
CK: Neutrophil-lymphocyte ratio, level as prognostic, predictive
factors in colorectal cancer: A systematic review and
meta-analysis. J Cancer Res Ther. 12:582–589. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Toiyama Y, Inoue Y, Saigusa S, Kawamura M,
Kawamoto A, Okugawa Y, Hiro J, Tanaka K, Mohri Y and Kusunoki M:
C-reactive protein as predictor of recurrence in patients with
rectal cancer undergoing chemoradiotherapy followed by surgery.
Anticancer Res. 33:5065–5074. 2013.PubMed/NCBI
|
|
35
|
Thirunavukarasu P, Sukumar S, Sathaiah M,
Mahan M, Pragatheeshwar KD, Pingpank JF, Zeh H III, Bartels CJ, Lee
KK and Bartlett DL: C-stage in colon cancer: Implications of
carcinoembryonic antigen biomarker in staging, prognosis, and
management. J Natl Cancer Inst. 103:689–697. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lakemeyer L, Sander S, Wittau M,
Henne-Bruns D, Kornmann M and Lemke J: Diagnostic and prognostic
value of CEA and CA19-9 in colorectal cancer. Diseases. 9:212021.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rao H, Wu H, Huang Q, Yu Z and Zhong Z:
Clinical value of serum CEA, CA24-2 and CA19-9 in patients with
colorectal cancer. Clin Lab. Apr 1–2021.(Epub ahead of print).
View Article : Google Scholar
|
|
38
|
Baxter NN, Kennedy EB, Bergsland E, Berlin
J, George TJ, Gill S, Gold PJ, Hantel A, Jones L, Lieu C, et al:
Adjuvant therapy for stage II colon cancer: ASCO guideline update.
J Clin Oncol. 40:892–910. 2022. View Article : Google Scholar : PubMed/NCBI
|
